• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow

The journey from ecstasy to medicine: Rick Doblin’s long, strange MDMA trip

by EmpathiCSubstanceS | Feb 3, 2018 | Addiction, Depression

For 35 years Rick Doblin has worked to bring MDMA back into the world of medicine In 1982, a young psychedelic researcher studying at the New College in Florida embarked upon a month long workshop with the godfather of psychedelic medical research Stanislav Grof at...

Magic mushrooms chemicals could help people with depression, says leading psychiatrist

by EmpathiCSubstanceS | Feb 3, 2018 | Addiction, Anxiety

Scientists are researching how psychoactive drugs could be used to treat mental illness in what is being hailed the psychedelic renaissance  A chemical in magic mushrooms could be used to treat people with depression who don’t respond to prescription drugs, according...

Live Every Day Like You’re on Mushrooms

by EmpathiCSubstanceS | Feb 3, 2018 | Addiction, Alcoholism

Hallucinogens may help people break free of destructive thoughts and addiction. Can a “mystical experience” be had legally? TOWSON, Maryland—Kathleen Conneally had smoked since she was 12, but one day in the spring of 2013, that changed in an instant. Conneally...

Nicholas Powers Ph.D. – Psychedelics, Race, Where They Intersect, and Where They Don’t

by EmpathiCSubstanceS | Feb 2, 2018 | Psychedelic Medicine

Podcast Show Topics Diversity in research Monica Williams – Diversity in the psychedelic research The trust between diverse populations and institutional research History of forced sterilizations and the Tuskegee syphilis study The importance of storytelling and...

Is Ayahuasca an Antidote to Modern Life?

by EmpathiCSubstanceS | Feb 2, 2018 | Psychedelic Medicine

Jeremy Narby, Ph.D. In 1995 I published a book called The Cosmic Serpent that dealt with ayahuasca and other subjects. The enthusiasm of many readers took me by surprise. In the book I describe ayahuasca as foul-tasting and my experience drinking it as an ordeal...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Neurosciences and psychotherapeutic applications in the psychedelic research renaissance

Aug 11, 2022

Psilocybin, a 5-HT2A receptor agonist has been associated with reduced activity in the Default- Mode Network (commonly activated during introspection and self-reflection), enhanced access to biographical memories, positive emotional attentional bias and a reduction on...

Altered Insula Connectivity under MDMA

Aug 11, 2022

Results revealed decreased right insula/salience network functional connectivity under MDMA. Furthermore, these decreases in right insula/salience network connectivity correlated with baseline trait anxiety and acute experiences of altered bodily sensations under...

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

Aug 11, 2022

For the interaction of OBN and DED with Time (QIDS-SR as dependent variable), the main effect and the effects at each time point compared to baseline were all significant (p = 0.002 and p = 0.003, respectively, for main effects), confirming our main hypothesis....

Psychedelic Medicine

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow